ArticleInternational journal of nanomedicine2016

Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging.

Antoine D'Hollander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.